Loading…

“It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care

Background: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. Purpose: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2...

Full description

Saved in:
Bibliographic Details
Published in:Patient preference and adherence 2022-08, Vol.16, p.2031-2039
Main Authors: Matthes, Anni, Wolf, Florian, Bleidorn, Jutta, Markwart, Robby
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3
cites cdi_FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3
container_end_page 2039
container_issue
container_start_page 2031
container_title Patient preference and adherence
container_volume 16
creator Matthes, Anni
Wolf, Florian
Bleidorn, Jutta
Markwart, Robby
description Background: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. Purpose: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2 testing conducted in primary care. Methods: We conducted a cross-sectional survey study among patients who were tested with a molecular SARS-CoV-2 rapid test (ID NOW[TM] COVID-19 rapid test, Abbott) in 13 primary care practices in the state of Thuringia (Germany) from February to April 2021. The following aspects were covered in the questionnaire through rating scales and open text formats: test characteristics, trust in test result, consequences of immediate result, cost amount willing to pay and expectations in the future. Open text answers were categorized; quantitative data were analyzed using descriptive statistics and a Mann--Whitney U-test to reveal differences in cost contribution depending on the test result. Results: A total of 215 patients from nine family practices and one pediatric practice participated. The immediate availability of the test result was important to the majority of patients (94.3%). 95.7% of patients trusted in their test result. Personal consequences of the immediate test result referred to pandemic measures, certainty of action and reassurance. For further tests, patients were willing to pay between 0[euro] and 100[euro] (interquartile range = 10-25[euro]) for the molecular SARS-CoV-2 POCT, regardless of the test result. Expectations of being offered the test again in case of renewed cold symptoms were reported by 96.2%. Conclusion: Patients highly appreciated molecular SARS-CoV-2 rapid testing conducted in primary care practices. The immediate availability of the test result led to adjustments in patients' behavior and emotional wellbeing. However, potentially challenging for the implementation of POCTs in primary care practices may be the reimbursement of test costs and patients' expectations in future situation. Keywords: POCT, rapid test, COVID-19, acceptance, feasibility
doi_str_mv 10.2147/PPA.S372366
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1c6441d8467645e9bca244f8db8a6f89</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A718217543</galeid><doaj_id>oai_doaj_org_article_1c6441d8467645e9bca244f8db8a6f89</doaj_id><sourcerecordid>A718217543</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3</originalsourceid><addsrcrecordid>eNptkk2LEzEYxwdR3HX15BcICCLI1GQmk5eLUIqrhZUt23X1FjKZpE2ZTrpJZmVvvXv0ql-un8T0BdmKzCFD8svvefLnybKXCA4KhOm7yWQ4mJa0KAl5lJ0iRGnOGP_2-MH_SfYshAWEpCQFepqdlBWnFaLFafZjs_41juCrDOBG-3swckvjfLTdDEQHzm3XgMs-gis7m0cw_C7vB5v1b7BZ_wQTGa3uIphoH1ZaRXunA3AdmDjbxdyZfCS9Bp9dq1XfSg-mw6tpPnI3eQGuddhVsIn2dim3dRP8PHtiZBv0i8N6ln05_3A9-pRfXH4cj4YXucIMxpxKyUoCdYGVrEgNa8gNI1xzaHTNag4RJdDUNcbG8JKShmklMUSImAqxxpRn2XjvbZxciNW-A-GkFbsN52dCpghUqwVSBGPUMEwowZXmtZJF8rKmZpIYxpPr_d616uulblRKxMv2SHp80tm5mLk7kTqrOGdJ8OYg8O62T8GIpQ1Kt63stOuDKCgsMaIclwl99Q-6cL3vUlQ7CrGS7jo6UDOZHmA741JdtZWKIUWsQLTauQb_odLX6KVVrtPGpv2jC68fXJhr2cZ5cG0frevCMfh2DyrvQvDa_A0DQbEdWJEGVhwGtvwDcbHb5w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2703183789</pqid></control><display><type>article</type><title>“It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care</title><source>Publicly Available Content Database</source><source>Taylor &amp; Francis Open Access Journals</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Matthes, Anni ; Wolf, Florian ; Bleidorn, Jutta ; Markwart, Robby</creator><creatorcontrib>Matthes, Anni ; Wolf, Florian ; Bleidorn, Jutta ; Markwart, Robby</creatorcontrib><description>Background: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. Purpose: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2 testing conducted in primary care. Methods: We conducted a cross-sectional survey study among patients who were tested with a molecular SARS-CoV-2 rapid test (ID NOW[TM] COVID-19 rapid test, Abbott) in 13 primary care practices in the state of Thuringia (Germany) from February to April 2021. The following aspects were covered in the questionnaire through rating scales and open text formats: test characteristics, trust in test result, consequences of immediate result, cost amount willing to pay and expectations in the future. Open text answers were categorized; quantitative data were analyzed using descriptive statistics and a Mann--Whitney U-test to reveal differences in cost contribution depending on the test result. Results: A total of 215 patients from nine family practices and one pediatric practice participated. The immediate availability of the test result was important to the majority of patients (94.3%). 95.7% of patients trusted in their test result. Personal consequences of the immediate test result referred to pandemic measures, certainty of action and reassurance. For further tests, patients were willing to pay between 0[euro] and 100[euro] (interquartile range = 10-25[euro]) for the molecular SARS-CoV-2 POCT, regardless of the test result. Expectations of being offered the test again in case of renewed cold symptoms were reported by 96.2%. Conclusion: Patients highly appreciated molecular SARS-CoV-2 rapid testing conducted in primary care practices. The immediate availability of the test result led to adjustments in patients' behavior and emotional wellbeing. However, potentially challenging for the implementation of POCTs in primary care practices may be the reimbursement of test costs and patients' expectations in future situation. Keywords: POCT, rapid test, COVID-19, acceptance, feasibility</description><identifier>ISSN: 1177-889X</identifier><identifier>EISSN: 1177-889X</identifier><identifier>DOI: 10.2147/PPA.S372366</identifier><identifier>PMID: 35975172</identifier><language>eng</language><publisher>Auckland: Dove Medical Press Limited</publisher><subject>acceptance ; Analysis ; Antigens ; Coronaviruses ; COVID-19 ; Epidemics ; Family medicine ; feasibility ; Health aspects ; Health care ; Health insurance ; Infections ; Laboratories ; Medical research ; Medicine, Experimental ; Original Research ; Pandemics ; Patients ; Pediatrics ; Physicians ; poct ; Primary care ; Quarantine ; Questionnaires ; rapid test ; Severe acute respiratory syndrome coronavirus 2 ; Surveys ; Willingness to pay</subject><ispartof>Patient preference and adherence, 2022-08, Vol.16, p.2031-2039</ispartof><rights>COPYRIGHT 2022 Dove Medical Press Limited</rights><rights>2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 Matthes et al. 2022 Matthes et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3</citedby><cites>FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3</cites><orcidid>0000-0003-1765-0344</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2703183789/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2703183789?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,38516,43895,44590,53791,53793,74412,75126</link.rule.ids></links><search><creatorcontrib>Matthes, Anni</creatorcontrib><creatorcontrib>Wolf, Florian</creatorcontrib><creatorcontrib>Bleidorn, Jutta</creatorcontrib><creatorcontrib>Markwart, Robby</creatorcontrib><title>“It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care</title><title>Patient preference and adherence</title><description>Background: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. Purpose: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2 testing conducted in primary care. Methods: We conducted a cross-sectional survey study among patients who were tested with a molecular SARS-CoV-2 rapid test (ID NOW[TM] COVID-19 rapid test, Abbott) in 13 primary care practices in the state of Thuringia (Germany) from February to April 2021. The following aspects were covered in the questionnaire through rating scales and open text formats: test characteristics, trust in test result, consequences of immediate result, cost amount willing to pay and expectations in the future. Open text answers were categorized; quantitative data were analyzed using descriptive statistics and a Mann--Whitney U-test to reveal differences in cost contribution depending on the test result. Results: A total of 215 patients from nine family practices and one pediatric practice participated. The immediate availability of the test result was important to the majority of patients (94.3%). 95.7% of patients trusted in their test result. Personal consequences of the immediate test result referred to pandemic measures, certainty of action and reassurance. For further tests, patients were willing to pay between 0[euro] and 100[euro] (interquartile range = 10-25[euro]) for the molecular SARS-CoV-2 POCT, regardless of the test result. Expectations of being offered the test again in case of renewed cold symptoms were reported by 96.2%. Conclusion: Patients highly appreciated molecular SARS-CoV-2 rapid testing conducted in primary care practices. The immediate availability of the test result led to adjustments in patients' behavior and emotional wellbeing. However, potentially challenging for the implementation of POCTs in primary care practices may be the reimbursement of test costs and patients' expectations in future situation. Keywords: POCT, rapid test, COVID-19, acceptance, feasibility</description><subject>acceptance</subject><subject>Analysis</subject><subject>Antigens</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Epidemics</subject><subject>Family medicine</subject><subject>feasibility</subject><subject>Health aspects</subject><subject>Health care</subject><subject>Health insurance</subject><subject>Infections</subject><subject>Laboratories</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Original Research</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Physicians</subject><subject>poct</subject><subject>Primary care</subject><subject>Quarantine</subject><subject>Questionnaires</subject><subject>rapid test</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Surveys</subject><subject>Willingness to pay</subject><issn>1177-889X</issn><issn>1177-889X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk2LEzEYxwdR3HX15BcICCLI1GQmk5eLUIqrhZUt23X1FjKZpE2ZTrpJZmVvvXv0ql-un8T0BdmKzCFD8svvefLnybKXCA4KhOm7yWQ4mJa0KAl5lJ0iRGnOGP_2-MH_SfYshAWEpCQFepqdlBWnFaLFafZjs_41juCrDOBG-3swckvjfLTdDEQHzm3XgMs-gis7m0cw_C7vB5v1b7BZ_wQTGa3uIphoH1ZaRXunA3AdmDjbxdyZfCS9Bp9dq1XfSg-mw6tpPnI3eQGuddhVsIn2dim3dRP8PHtiZBv0i8N6ln05_3A9-pRfXH4cj4YXucIMxpxKyUoCdYGVrEgNa8gNI1xzaHTNag4RJdDUNcbG8JKShmklMUSImAqxxpRn2XjvbZxciNW-A-GkFbsN52dCpghUqwVSBGPUMEwowZXmtZJF8rKmZpIYxpPr_d616uulblRKxMv2SHp80tm5mLk7kTqrOGdJ8OYg8O62T8GIpQ1Kt63stOuDKCgsMaIclwl99Q-6cL3vUlQ7CrGS7jo6UDOZHmA741JdtZWKIUWsQLTauQb_odLX6KVVrtPGpv2jC68fXJhr2cZ5cG0frevCMfh2DyrvQvDa_A0DQbEdWJEGVhwGtvwDcbHb5w</recordid><startdate>20220831</startdate><enddate>20220831</enddate><creator>Matthes, Anni</creator><creator>Wolf, Florian</creator><creator>Bleidorn, Jutta</creator><creator>Markwart, Robby</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7XB</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>KB0</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-1765-0344</orcidid></search><sort><creationdate>20220831</creationdate><title>“It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care</title><author>Matthes, Anni ; Wolf, Florian ; Bleidorn, Jutta ; Markwart, Robby</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>acceptance</topic><topic>Analysis</topic><topic>Antigens</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Epidemics</topic><topic>Family medicine</topic><topic>feasibility</topic><topic>Health aspects</topic><topic>Health care</topic><topic>Health insurance</topic><topic>Infections</topic><topic>Laboratories</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Original Research</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Physicians</topic><topic>poct</topic><topic>Primary care</topic><topic>Quarantine</topic><topic>Questionnaires</topic><topic>rapid test</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Surveys</topic><topic>Willingness to pay</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matthes, Anni</creatorcontrib><creatorcontrib>Wolf, Florian</creatorcontrib><creatorcontrib>Bleidorn, Jutta</creatorcontrib><creatorcontrib>Markwart, Robby</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Patient preference and adherence</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matthes, Anni</au><au>Wolf, Florian</au><au>Bleidorn, Jutta</au><au>Markwart, Robby</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>“It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care</atitle><jtitle>Patient preference and adherence</jtitle><date>2022-08-31</date><risdate>2022</risdate><volume>16</volume><spage>2031</spage><epage>2039</epage><pages>2031-2039</pages><issn>1177-889X</issn><eissn>1177-889X</eissn><abstract>Background: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. Purpose: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2 testing conducted in primary care. Methods: We conducted a cross-sectional survey study among patients who were tested with a molecular SARS-CoV-2 rapid test (ID NOW[TM] COVID-19 rapid test, Abbott) in 13 primary care practices in the state of Thuringia (Germany) from February to April 2021. The following aspects were covered in the questionnaire through rating scales and open text formats: test characteristics, trust in test result, consequences of immediate result, cost amount willing to pay and expectations in the future. Open text answers were categorized; quantitative data were analyzed using descriptive statistics and a Mann--Whitney U-test to reveal differences in cost contribution depending on the test result. Results: A total of 215 patients from nine family practices and one pediatric practice participated. The immediate availability of the test result was important to the majority of patients (94.3%). 95.7% of patients trusted in their test result. Personal consequences of the immediate test result referred to pandemic measures, certainty of action and reassurance. For further tests, patients were willing to pay between 0[euro] and 100[euro] (interquartile range = 10-25[euro]) for the molecular SARS-CoV-2 POCT, regardless of the test result. Expectations of being offered the test again in case of renewed cold symptoms were reported by 96.2%. Conclusion: Patients highly appreciated molecular SARS-CoV-2 rapid testing conducted in primary care practices. The immediate availability of the test result led to adjustments in patients' behavior and emotional wellbeing. However, potentially challenging for the implementation of POCTs in primary care practices may be the reimbursement of test costs and patients' expectations in future situation. Keywords: POCT, rapid test, COVID-19, acceptance, feasibility</abstract><cop>Auckland</cop><pub>Dove Medical Press Limited</pub><pmid>35975172</pmid><doi>10.2147/PPA.S372366</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-1765-0344</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1177-889X
ispartof Patient preference and adherence, 2022-08, Vol.16, p.2031-2039
issn 1177-889X
1177-889X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_1c6441d8467645e9bca244f8db8a6f89
source Publicly Available Content Database; Taylor & Francis Open Access Journals; PubMed Central; Coronavirus Research Database
subjects acceptance
Analysis
Antigens
Coronaviruses
COVID-19
Epidemics
Family medicine
feasibility
Health aspects
Health care
Health insurance
Infections
Laboratories
Medical research
Medicine, Experimental
Original Research
Pandemics
Patients
Pediatrics
Physicians
poct
Primary care
Quarantine
Questionnaires
rapid test
Severe acute respiratory syndrome coronavirus 2
Surveys
Willingness to pay
title “It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T18%3A20%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%E2%80%9CIt%20Was%20Very%20Comforting%20to%20Find%20Out%20Right%20Away.%E2%80%9D%20%E2%80%93%20Patient%20Perspectives%20on%20Point-of-Care%20Molecular%20SARS-CoV-2%20Testing%20in%20Primary%20Care&rft.jtitle=Patient%20preference%20and%20adherence&rft.au=Matthes,%20Anni&rft.date=2022-08-31&rft.volume=16&rft.spage=2031&rft.epage=2039&rft.pages=2031-2039&rft.issn=1177-889X&rft.eissn=1177-889X&rft_id=info:doi/10.2147/PPA.S372366&rft_dat=%3Cgale_doaj_%3EA718217543%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2703183789&rft_id=info:pmid/35975172&rft_galeid=A718217543&rfr_iscdi=true